Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Oryctolagus cuniculus | Angiotensin-converting enzyme | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Brugia malayi | Angiotensin-converting enzyme family protein | Get druggable targets OG5_131988 | All targets in OG5_131988 |
Loa Loa (eye worm) | angiotensin-converting enzyme family protein | Get druggable targets OG5_131988 | All targets in OG5_131988 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | Excitatory amino acid transporter | 0.4464 | 1 | 1 |
Echinococcus granulosus | sodium:dicarboxylate symporter | 0.4464 | 1 | 0.5 |
Mycobacterium tuberculosis | Probable C4-dicarboxylate-transport transmembrane protein DctA | 0.4464 | 1 | 0.5 |
Loa Loa (eye worm) | excitatory amino acid transporter | 0.4464 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | Na+/H+-dicarboxylate symporter | 0.4464 | 1 | 0.5 |
Echinococcus multilocularis | sodium:dicarboxylate symporter | 0.4464 | 1 | 1 |
Echinococcus multilocularis | neutral amino acid transporter A | 0.4464 | 1 | 1 |
Treponema pallidum | glutamate transporter | 0.1979 | 0.331 | 0.5 |
Echinococcus granulosus | neutral amino acid transporter A | 0.4464 | 1 | 0.5 |
Schistosoma mansoni | solute carrier family 1 (glial high affinity glutamate transporter | 0.4464 | 1 | 1 |
Echinococcus granulosus | excitatory amino acid transporter 2 | 0.4464 | 1 | 0.5 |
Onchocerca volvulus | Excitatory amino acid transporter homolog | 0.4464 | 1 | 0.5 |
Echinococcus multilocularis | excitatory amino acid transporter 3 | 0.4464 | 1 | 1 |
Echinococcus multilocularis | excitatory amino acid transporter 2 | 0.4464 | 1 | 1 |
Echinococcus granulosus | neutral amino acid transporter A | 0.4464 | 1 | 0.5 |
Echinococcus granulosus | neutral amino acid transporter | 0.4464 | 1 | 0.5 |
Echinococcus multilocularis | neutral amino acid transporter excitatory amino acid transporter | 0.4464 | 1 | 1 |
Echinococcus multilocularis | excitatory amino acid transporter 2 | 0.4464 | 1 | 1 |
Treponema pallidum | glutamate/aspartate transporter | 0.1979 | 0.331 | 0.5 |
Echinococcus multilocularis | Excitatory amino acid transporter | 0.4464 | 1 | 1 |
Echinococcus granulosus | excitatory amino acid transporter 3 | 0.4464 | 1 | 0.5 |
Echinococcus multilocularis | neutral amino acid transporter A | 0.4464 | 1 | 1 |
Echinococcus granulosus | Excitatory amino acid transporter | 0.4464 | 1 | 0.5 |
Echinococcus granulosus | excitatory amino acid transporter 2 | 0.4464 | 1 | 0.5 |
Echinococcus granulosus | Excitatory amino acid transporter | 0.4464 | 1 | 0.5 |
Echinococcus multilocularis | neutral amino acid transporter A | 0.4464 | 1 | 1 |
Chlamydia trachomatis | glutamate symporter | 0.4464 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
ED50 (functional) | = 300 ug kg-1 | Effective dose against ACE inhibitory activity in rat in vivo | ChEMBL. | 2983075 |
IC50 (binding) | = 0.00000028 uM | In vitro inhibitory activity of the compound against Angiotensin I converting enzyme | ChEMBL. | 2983075 |
IC50 (binding) | = 0.00000028 uM | In vitro inhibitory activity of the compound against Angiotensin I converting enzyme | ChEMBL. | 2983075 |
Mean decrease (functional) | = 85 % | In vivo percent mean decrease in Angiotensin I converting enzyme inhibitory activity in 5 rats administered perorally at a dose of 10 mg/kg | ChEMBL. | 2983075 |
Mean decrease (functional) | = 85 % | In vivo percent mean decrease in Angiotensin I converting enzyme inhibitory activity in 5 rats administered perorally at a dose of 10 mg/kg | ChEMBL. | 2983075 |
Mean duration (functional) | > 4 hr | In vivo mean duration for Angiotensin I converting enzyme inhibitory activity in 5 rats administered perorally at a dose of 10 mg/kg | ChEMBL. | 2983075 |
Mean duration (functional) | > 4 hr | In vivo mean duration for Angiotensin I converting enzyme inhibitory activity in 5 rats administered perorally at a dose of 10 mg/kg | ChEMBL. | 2983075 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.